Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and PET Imaging in NSCLC
NCT00453362Phase 2Completed
- Sponsor
- Genentech
- Start
- Dec 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Genentech. Started Dec 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00453362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453362.